publication date: Apr. 3, 2015

Cold Spring Harbor Laboratory and North Shore-LIJ to Form $120 Million Collaboration

 

Bruce Stillman, president and CEO of CSHL, and Michael J. Dowling, president and CEO of the North Shore-LIJ Health System

 

 

 

Two New York institutions—Cold Spring Harbor Laboratory and the North Shore-LIJ Health System—announced a $120 million cancer research collaboration on April 2.

The collaboration aims to develop a clinical cancer research unit at the North Shore-LIJ Cancer Institute’s headquarters in Lake Success, N.Y., support early-phase clinical studies, and recruit and train clinician-scientists.

North Shore-LIJ and CSHL will continue as independent organizations governed by their respective boards of trustees. The sources of funds for the collaboration were not disclosed.

“This is a transformative affiliation for both institutions, bringing the cutting-edge basic discovery science and translational cancer research at CSHL to one of the largest cancer treatment centers in the United States. The unique integration of research scientists, clinical translational researchers and cancer clinicians promises to speed the advance of novel cancer diagnostics and therapeutics to patients in the region,” CSHL President & CEO Bruce Stillman said in a statement.

The institutions appointed a six-member committee to oversee the collaboration. They are, on CSHL’s side: Stillman; David Spector, director of research; and David Tuveson, cancer center deputy director. The three representatives of North Shore-LIJ are: Physician-in-Chief Lawrence Smith; Kevin Tracey, president and CEO of the Feinstein Institute for Medical Research; and Thomas McGinn, chair of medicine.

Under the collaboration, clinician-scientists will be trained to perform preclinical cancer research and conduct early-stage human clinical trials.

Advanced-phase clinical trials would be conducted … Continue reading 41-13 Cold Spring Harbor Laboratory and North Shore-LIJ to Form $120 Million Collaboration

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.